THERACAP 131 37MBq-5.55GBq capsules medication leaflet

V10XA01 sodium iodide (131I) • Various | Other therapeutic radiopharmaceuticals | Iodine (131i) compounds

Natrii iodidum (131I) is a radioactive compound used in the treatment and diagnosis of thyroid conditions such as hyperthyroidism and thyroid cancer. It emits radiation that destroys overactive or cancerous thyroid cells.

It is administered orally, in capsule or solution form, and is quickly absorbed by the thyroid gland. Treatment with Natrii iodidum (131I) is effective and minimally invasive, serving as an alternative to surgical interventions.

Side effects may include dry mouth, fatigue, or inflammation of the salivary glands. As a radioactive compound, its use requires special precautions to minimize radiation exposure.

Consult your doctor to discuss the benefits and risks of treatment with Natrii iodidum (131I). It is important to follow all instructions to ensure the safety and effectiveness of the treatment.

General data about THERACAP 131 37MBq-5.55GBq

Substance: sodium iodide (131I)

Date of last drug list: 01-03-2022

Commercial code: W66155003

Concentration: 37MBq-5.55GBq

Pharmaceutical form: capsules

Quantity: 1

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: GE HEALTHCARE BUCHLER GMBH & CO. KG - GERMANIA

Holder: GE HEALTHCARE BUCHLER GMBH & CO. KG - GERMANIA

Number: 9322/2016/01

Shelf life: 14 days, dupa data de referinta

Concentrations available for sodium iodide (131I)

0.333 MBq - 3.7 MBq, 0.37-3.7GBq, 0.37-36MBq, 14.8-3700MBq, 3.7MBq, 3.7MBq.1.85MBq.0.925MBq, 37-5500MBq, 37-7400MBq, 37MBq-5.55GBq, 38-7400MBq, 50- 7400MBq